Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...
主要な著者: | Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Oxford University Press
2019
|
類似資料
-
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
著者:: Wang, Y, 等
出版事項: (2020) -
Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
著者:: Parvaiz A Koul, 等
出版事項: (2024-01-01) -
Does Oseltamivir Really Reduce Complications of Influenza?
著者:: Del Mar, C, 等
出版事項: (2011) -
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
著者:: Chairat, K, 等
出版事項: (2016) -
Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
著者:: Mihai Maria Elena, 等
出版事項: (2024-04-01)